March 10, 2025 - 20:25

The World Health Organization is sounding the alarm on a potential surge in tuberculosis cases due to recent USAID funding cuts. Officials from the WHO have expressed deep concern that decreased financial support could hinder ongoing efforts to combat the disease, which remains a significant public health challenge worldwide.
Tuberculosis, a highly infectious disease, has seen a resurgence in some areas, particularly in low- and middle-income countries where healthcare resources are already stretched thin. The cuts in funding from USAID could exacerbate the situation, as many programs rely heavily on this support to provide essential services such as testing, treatment, and prevention strategies.
Health experts warn that without adequate resources, the progress made in reducing tuberculosis incidence over the past few years could be reversed, leading to increased morbidity and mortality rates. The WHO is urging governments and international partners to reconsider funding cuts and prioritize the fight against tuberculosis to safeguard public health globally.
October 21, 2026 - 01:41
Ebola Case Confirmed in Abuja After Traveler Arrives From UgandaNigeria has confirmed an Ebola case in Abuja after a woman arriving from Uganda tested positive, making the country the latest in the region to report an infection as the outbreak continues to...
October 20, 2026 - 03:18
CIM Holds Annual Health and Benefits Fair for StaffThe California Institution for Men in Chino recently hosted its yearly Employee Health and Benefits Fair, giving staff a chance to learn about the resources available to them and their...
October 19, 2026 - 05:23
Health Officials Push for Flu Vaccinations as Early Cases Rise in Some StatesVirginia health officials are urging residents to get their flu shots as data from other parts of the country points to an early jump in infections this season. So far, only about 10 percent of...
October 18, 2026 - 21:18
VA Doctor Leads National Trial on GLP-1 Drugs for Alcohol Use DisorderA physician at the Philadelphia Veterans Affairs Medical Center is heading a nationwide clinical trial that will examine whether GLP-1 receptor agonists, the class of medications best known for...